Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31097405

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Jun
First author
Richardson PG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jun;20(6):743-744. doi: 10.1016/S1470-2045(19)30295-5.
    note
    Source null
    related pmid
    31097404
    relationship
    Comment in

Authors and identifiers

  1. name
    Richardson PG
    type
    Author
  2. name
    Oriol A
    type
    Author
  3. name
    Beksac M
    type
    Author
  4. name
    Liberati AM
    type
    Author
  5. name
    Galli M
    type
    Author
  6. name
    Schjesvold F
    type
    Author
  7. name
    Lindsay J
    type
    Author
  8. name
    Weisel K
    type
    Author
  9. name
    White D
    type
    Author
  10. name
    Facon T
    type
    Author
  11. name
    San Miguel J
    type
    Author
  12. name
    Sunami K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Richardson PG
    type
    Author
  2. name
    Oriol A
    type
    Author
  3. name
    Beksac M
    type
    Author
  4. name
    Liberati AM
    type
    Author
  5. name
    Galli M
    type
    Author
  6. name
    Schjesvold F
    type
    Author
  7. name
    Lindsay J
    type
    Author
  8. name
    Weisel K
    type
    Author
  9. name
    White D
    type
    Author
  10. name
    Facon T
    type
    Author
  11. name
    San Miguel J
    type
    Author
  12. name
    Sunami K
    type
    Author
bibliography ids
  1. nci-bib-bb7f2aa546a5fdf7c0625fff
book metadata
content sha256
1625e344b8158040a88d2e94ea7dba9f8f9039fe24a76731b6681b4accdbfadc
document type
citation
dois
  1. 10.1016/S1470-2045(19)30152-4
electronic publication date
display
2019 May 13
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31097405
immutable id
pubmed:31097405@1625e344b8158040a88d2e94ea7dba9f8f9039fe24a76731b6681b4accdbfadc
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
781-794
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jun;20(6):743-744. doi: 10.1016/S1470-2045(19)30295-5.
    note
    Source null
    related pmid
    31097404
    relationship
    Comment in
outcomes validated
false
pmid
31097405
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
67873805d927b781df35f63c98b1ba0f5c44840db7161cf897b50353c59835a5
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Jun
precision
month
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31097405/
title
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.

Preserved source evidence · Not medical advice